More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Cucurbitacin E [18444-66-1]
Chemical Structure
Chemical Structure
Chemical Structure

Cucurbitacin E [18444-66-1]

Research Use Only
AG-CN2-0474
AdipoGen Life Sciences
CAS Number18444-66-1
DownloadMSDS
Product group Chemicals
Estimated Purity>98%
Molecular Weight556.7
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    AdipoGen Life Sciences
  • Product Name
    Cucurbitacin E
  • Delivery Days Customer
    10
  • CAS Number
    18444-66-1
  • Certification
    Research Use Only
  • Estimated Purity
    >98%
  • Hazard Information
    Warning
  • Molecular Formula
    C32H44O8
  • Molecular Weight
    556.7
  • Scientific Description
    Chemical. CAS: 18444-66-1. Formula: C32H44O8. MW: 556.7. Isolated from Cucumis melo L. Potent actin depolymerization inhibitor. Shown to have a different mechanism of action compared to jasplakinolide (Prod. No. AG-CN2-0037), binding to a different site. Binds specifically to filamentous actin (F-actin) forming a covalent bond at residue Cys257, stabilizing F-actin without affecting actin polymerization or nucleation. Does not bind to monomeric actin (G-actin). Immunomodulator with anti-inflammatory and anti-tumorigenic properties in a range of cancer cell lines, mediated by its action on the cellular cytoskeleton, on mitotic pathways as well as on cellular autophagy. Shown to induce apoptosis, autophagy and cell cycle arrest at G2/M. Inhibits tumor angiogenesis through Jak-STAT3 signaling pathway, suppresses cell migration and invasion, and inhibits NF-kappaB nuclear translocation. Antioxidant and potential neuroprotective compound with potential neurodegenerative properties. - Potent actin depolymerization inhibitor. Shown to have a different mechanism of action compared to jasplakinolide (Prod. No. AG-CN2-0037), binding to a different site. Binds specifically to filamentous actin (F-actin) forming a covalent bond at residue Cys257, stabilizing F-actin without affecting actin polymerization or nucleation. Does not bind to monomeric actin (G-actin). Immunomodulator with anti-inflammatory and anti-tumorigenic properties in a range of cancer cell lines, mediated by its action on the cellular cytoskeleton, on mitotic pathways as well as on cellular autophagy. Shown to induce apoptosis, autophagy and cell cycle arrest at G2/M. Inhibits tumor angiogenesis through Jak-STAT3 signaling pathway, suppresses cell migration and invasion, and inhibits NF-kappaB nuclear translocation. Antioxidant and potential neuroprotective compound with potential neurodegenerative properties.
  • SMILES
    [H][C@@]1([C@H](O)C[C@@]2(C)[C@]3([H])CC=C4[C@@]([H])(C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C)[C@@](C)(O)C(=O)\C=C\C(C)(C)OC(C)=O
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352200

References

  • Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells: K.L. Duncan, et al.; Biochem. Pharmacol. 52, 1553 (1996)
  • Cucurbitacin glucosides: antioxidant and free-radical scavenging activities: T. Tannin-Spitz, et al.; BBRC 364, 181 (2007)
  • Direct interaction of Cucurbitacin E isolated from Alsomitra macrocarpa to actin filament: K. Momma, et al.; Cytotechnology 56, 33 (2008)
  • Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway: Y. Dong, et al.; Carcinogenesis 31, 2097 (2010)
  • Cucurbitacin E Induces G(2)/M Phase Arrest through STAT3/p53/p21 Signaling and Provokes Apoptosis via Fas/CD95 and Mitochondria-Dependent Pathways in Human Bladder Cancer T24 Cells: W.W. Huang, et al.; Evid. Based Complement Alternat. Med. 2012, 952762 (2012)
  • The natural product cucurbitacin E inhibits depolymerization of actin filaments: P.M. Soerensen, et al.; ACS Chem. Biol. 7, 1502 (2012)
  • Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion: T. Zhang, et al.; Breast Cancer Res. Treat. 135, 445 (2012)
  • Cucurbitacin E exhibits anti-inflammatory effect in RAW 264.7 cells via suppression of NF-kappaB nuclear translocation: J. Qiao, et al.; Inflamm. Res. 62, 461 (2013)
  • Cucurbitacin E as inducer of cell death and apoptosis in human oral squamous cell carcinoma cell line SAS: C.M. Hung, et al.; Int. J. Mol. Sci. 14, 17147 (2013)
  • Cucurbitacin E has neuroprotective properties and autophagic modulating activities on dopaminergic neurons: A.M. Arel-Dubeau, et al.; Oxid. Med. Cell Longev. 2014, 425496 (2014)